Detalhe da pesquisa
1.
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer.
Cancer
; 130(10): 1758-1765, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422026
2.
Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Gynecol Oncol
; 182: 63-69, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262240
3.
Metformin Pre-Treatment as a Means of Mitigating Disuse-Induced Rat Soleus Muscle Wasting.
Curr Issues Mol Biol
; 45(4): 3068-3086, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185725
4.
A Prochlorperazine-Induced Decrease in Autonomous Muscle Activity during Hindlimb Unloading Is Accompanied by Preserved Slow Myosin mRNA Expression.
Curr Issues Mol Biol
; 45(7): 5613-5630, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37504270
5.
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
Cancer
; 129(11): 1723-1734, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869646
6.
Effect of enhanced muscle tone on the expression of atrogenes and cytoskeletal proteins during postural muscle unloading.
Arch Biochem Biophys
; 725: 109291, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597296
7.
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer.
Gynecol Oncol
; 167(2): 334-341, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117009
8.
Role of Pannexin 1 ATP-Permeable Channels in the Regulation of Signaling Pathways during Skeletal Muscle Unloading.
Int J Mol Sci
; 22(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638792
9.
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast Cancer.
JCO Precis Oncol
; 8: e2300456, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691816
10.
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.
Mol Oncol
; 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037739
11.
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Cancer Cell
; 41(6): 1091-1102.e4, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146605
12.
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy.
Front Oncol
; 13: 1253629, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795442
13.
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.
JCO Precis Oncol
; 6: e2200148, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170624
14.
Impact of Circulating Tumor DNA-Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors.
JCO Precis Oncol
; 6: e2100181, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263168
15.
Prochlorperazine Withdraws the Delayed Onset Tonic Activity of Unloaded Rat Soleus Muscle: A Pilot Study.
Life (Basel)
; 11(11)2021 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34833037
16.
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk.
NPJ Breast Cancer
; 7(1): 32, 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767190
17.
Reply to S. Di Cosimo et al.
JCO Precis Oncol
; 7: e2200644, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701653
18.
Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
Mol Cell Biol
; 30(22): 5260-72, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20855524
19.
Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
Mol Cancer Res
; 8(2): 183-93, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124470
20.
ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
Cancer Res
; 70(22): 9402-12, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20864510